The Hindu (Thiruvananthapuram)
Nobel laureate and molecular biologist Venki Ramakrishnan discusses why death is inevitable and how techno-fantasies of living forever are scientically unfounded
Nobel Prize-winning molecular biologist Venki Ramakrishnan, in his new book Why We Die:
The New Science of Ageing and the Quest for Immortality (Hachette India/Hodder & Stoughton), says that while we better understand, at a biological level, the causes of ageing and death, we are far from major breakthroughs. With several technology mavens, including Amazon founder Je Bezos and Facebook creator Mark Zuckerberg, investing millions in ageing-related research, and many others self-experimenting with supplements and therapies to halt ageing, the eld is generating great interest among people of all ages. However, much of this doesn’t yet have the sound backing of scientic validation, says the
U.K.-based Ramakrishnan,
72. Edited excerpts from a Zoom interview:
After your last book, Gene Machine, a memoir and your own investigation into ribosomes, what made you focus on ageing and longevity?
Humanity has wondered for a long time about why we die and what limits lifespan. We’re probably the only species that knows about our mortality. We know that because we have developed language and ability to communicate and ever since, humans have wondered about mortality. This is an existential question. It is only in the last 50 years that we’ve come to grips with the underlying biology of why we age and what eventually causes death. A lot of things are happening in the eld. At the same time, there’s also an enormous amount of hype in the eld because there’s a lot of private investment. There are people who want to extend lifespan. Societies are growing older around the world. So, I wanted to discuss all that and felt there was a need for someone who’s a molecular biologist but who also doesn’t have a vested interest in the eld. My work on protein synthesis is related to one of the central causes of ageing. So, you can think of me as somebody who works in an area close to ageing, but I don’t work on ageing myself. That also makes me less, I would say, ideological or biased.
You mention how there’s huge private investment (in arresting ageing) and how several (Silicon Valley) tech billionaires are interested. Is this historically unprecedented?
There are now about 700 companies, start-up companies, which tackle dierent kinds of longevity research. And, you know, many tens of billions of dollars. People will say that’s a very small fraction (about 1%) of the research enterprise. But I would say, in terms of increase in investment and in absolute numbers, it’s still quite a large amount. Having so many people suddenly interested in ‘solving’ ageing is unprecedented because for a long time, ageing was considered a sort of backwater in science. I think that has changed over the last maybe 30 or 40 years. Part of
Q:A:the reason is that the [developed] world is facing an ageing population. India is an exception in that it still has a relatively young population. But as life expectancy increases in India, it too will face the same problem that all countries go through as they develop, which is that as people start living longer, fertility rates go down and you’re left with a dierent [population] distribution. And so, there’s a real need to make sure that people are healthy when they age. If they’re not healthy, it will impose huge burdens on the rest of society because there’ll be an increasing fraction of society that needs care. So there’s a lot of incentive for governments and others to invest in ageing research. It’s not just these billionaires who are afraid of getting old.
There seems to be this obsession with trying to be younger as you age. You give the example of Bryan Johnson (American tech-millionaire) who does blood-plasma transfusions, including from his 17-year-old son. What’s the scientic basis for that?
Being healthy when you’re old is almost the same thing as being young because you’re eliminating the problems of being old. But in terms of
Q:A:Bryan Johnson, he spends $2 million a year on anti-ageing measures, including collecting vast amounts of data. It suggests that he’s got some terrible fear of growing old. That’s ne. He’s entitled to doing whatever he wants with his money, right? And some of the things he does are actually based on some real science. It’s just that they’re not proven methods in humans. There have been no clinical trials to show ecacy and safety in humans. But he’s willing to take that risk.
If we had cures for heart disease, Alzheimer’s and cancer — the top three causes of age-related
Q: